Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine

2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13438 ;PMID: 29121415

Full text available